ACOT13 and ovarian serous cystadenocarcinoma: In reproductive system tumors, some studies have analyzed the clinicopathological parameters and the relationship of prognosis between ACOT13 and ovarian serous cystadenocarcinoma (52) by bioinformatics,and found that ACOT13 had low expression in normal ovarian tissue, but high expression in ovarian serous cystadenocarcinoma tissue, and correlated with the tumor stage.